GL1X · GenesisL1 explorer

Research workbench

Structural and biochemical analyses of the catalysis and potency impact of inhibitor phosphoribosylation by human nicotinamide phosphoribosyltransferase

Analyse Structural and biochemical analyses of the catalysis and potency impact of… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4O0Z
Type
protein
Length
940 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nicotinamide phosphoribosyltransferase
EC
2.4.2.12
UniProt
P43490
Ligands
2RM, PO4
Pockets
7 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANicotinamide phosphoribosyltransferase (EC 2.4.2.12)protein47141% helix, 19% strandP43490
BNicotinamide phosphoribosyltransferase (EC 2.4.2.12)protein46941% helix, 19% strandP43490

Ligands and binding sites

  • 2RM · N-{4-[(3,5-difluorophenyl)sulfonyl]benzyl}indolizine-6-carboxamide · ligand · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17790.800.8379PO4, 2RM
28000.800.83872RM, PO4
36880.730.7960empty
4800.360.7717empty
5700.350.7717empty

Interfaces

1 interface between chains.

  • A–B · 4317 Ų buried · 76 hydrogen bonds · protein-protein

Compared structures

  • 4O0Z · Structural and Biochemical Analyses of the Catalysis and Potency Impact of Inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.